Literature DB >> 25680579

Engineering control into medicine.

David J Stone1, Leo Anthony Celi2, Marie Csete3.   

Abstract

The human body is a tightly controlled engineering miracle. However, medical training generally does not cover "control" (in the engineering sense) in physiology, pathophysiology, and therapeutics. A better understanding of how evolved controls maintain normal homeostasis is critical for understanding the failure mode of controlled systems, that is, disease. We believe that teaching and research must incorporate an understanding of the control systems in physiology and take advantage of the quantitative tools used by engineering to understand complex systems. Control systems are ubiquitous in physiology, although often unrecognized. Here we provide selected examples of the role of control in physiology (heart rate variability, immunity), pathophysiology (inflammation in sepsis), and therapeutic devices (diabetes and the artificial pancreas). We also present a high-level background to the concept of robustly controlled systems and examples of clinical insights using the controls framework.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artificial pancreas; Autoimmune disease; Control systems; Heart rate variability; Sepsis

Mesh:

Year:  2015        PMID: 25680579      PMCID: PMC4414787          DOI: 10.1016/j.jcrc.2015.01.019

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  35 in total

1.  Dynamical modelling of haematopoiesis: an integrated view over the system in homeostasis and under perturbation.

Authors:  Erica Manesso; José Teles; David Bryder; Carsten Peterson
Journal:  J R Soc Interface       Date:  2013-03-06       Impact factor: 4.118

2.  Parallels between cancer and infectious disease.

Authors:  Richard S Hotchkiss; Lyle L Moldawer
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

Review 3.  The mathematician's control toolbox for management of type 1 diabetes.

Authors:  Marie Csete; John Doyle
Journal:  Interface Focus       Date:  2014-10-06       Impact factor: 3.906

Review 4.  Polycythemia vera and essential thrombocythemia: new developments in biology with therapeutic implications.

Authors:  Gabriela Soriano; Mark Heaney
Journal:  Curr Opin Hematol       Date:  2013-03       Impact factor: 3.284

5.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

6.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

7.  Genomic responses in mouse models poorly mimic human inflammatory diseases.

Authors:  Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

Review 8.  Preparing the ground for tissue regeneration: from mechanism to therapy.

Authors:  Stuart J Forbes; Nadia Rosenthal
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

Review 9.  Artificial pancreas: past, present, future.

Authors:  Claudio Cobelli; Eric Renard; Boris Kovatchev
Journal:  Diabetes       Date:  2011-11       Impact factor: 9.461

10.  Dynamic clinical data mining: search engine-based decision support.

Authors:  Leo Anthony Celi; Andrew J Zimolzak; David J Stone
Journal:  JMIR Med Inform       Date:  2014-06-23
View more
  3 in total

Review 1.  Personalized physiological medicine.

Authors:  Can Ince
Journal:  Crit Care       Date:  2017-12-28       Impact factor: 9.097

2.  Intensive care medicine in 2050: the ICU in vivo.

Authors:  Can Ince
Journal:  Intensive Care Med       Date:  2017-05-08       Impact factor: 17.440

Review 3.  Physiology and technology for the ICU in vivo.

Authors:  Can Ince
Journal:  Crit Care       Date:  2019-06-14       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.